Pubblicazioni

Autori:

Caminati, Marco; Carpagnano, LUCIA FEDERICA; Alberti, Chiara; Amaddeo, Francesco; Bixio, Riccardo; Caldart, Federico; DE FRANCESCHI, Lucia; DEL GIGLIO, Micol; Festi, Giuliana; Friso, Simonetta; Frulloni, Luca; Gisondi, Paolo; Krampera, Mauro; Lippi, Giuseppe; Micheletto, Claudio; Piacentini, Giorgio; Pinter, Patrick; Rossini, Maurizio; Schiappoli, Michele; Tecchio, Cristina; Tenero, Laura; Tinazzi, Elisa; Senna, Gianenrico; Carlucci, Matilde

Titolo:

Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach

Anno:

2024

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Formato:

Elettronico

Referee:

Sì

Nome rivista:

THE WORLD ALLERGY ORGANIZATION JOURNAL

ISSN Rivista:

1939-4551

N° Volume:

17

Numero o Fascicolo:

8

Intervallo pagine:

1-15

Parole chiave:

Hypereosinophilic syndrome, Mepolizumab, Benralizumab, Multidisciplinary, Precision medicine

Breve descrizione dei contenuti:

Hypereosinophilic syndromes (HES) represent a group of rare dis-immune conditions characterized by blood hyper-eosinophilia and eosinophilic related burden. Especially the idiopathic subtype (I-HES) is particularly difficult to diagnose because of its heterogeneous clinical presentation, the lack of specific findings on physical exam, lab tools, and imaging informative enough to unequivocally confirm the diagnosis and the overlap with other entities, including eosinophilic organ-diseases or systemic dis-immune conditions other than I-HES (from atopy to eosinophilic granulomatosis with polyangiitis [EGPA], the last often extremely difficult to distinguish from HES). Taken together, all the features mentioned above account for an extremely difficult early recognition HES and on-time referral to a specialized centre. The referral itself is challenging due to a not univocal specialist identification, because of the variability of physicians managing HES in different settings (including allergist/clinical immunologist, haematologist, internal medicine doctors, pulmonologist, rheumatologist). Furthermore, the approach in terms of personalized treatment identification and follow-up plan (timing, organ assessment), is poorly standardized. Further translational and clinical research is needed to address the mentioned unmet needs, but on practical grounds increasing the overall clinicians’ awareness on HES and implementing healthcare pathways for HES patients represent a roadmap that every clinician might try to realize in his specific setting. The present review aims at providing an overview about the current challenges and unmet needs in the practical approach to HES and rare hypereosinophilic allergo-immunological diseases, including a proposal for an innovative multidisciplinary organizational model.

Pagina Web:

https://www.sciencedirect.com/science/article/pii/S1939455124000590

Id prodotto:

140640

Handle IRIS:

11562/1132226

ultima modifica:

27 settembre 2024

Citazione bibliografica:

Caminati, Marco; Carpagnano, LUCIA FEDERICA; Alberti, Chiara; Amaddeo, Francesco; Bixio, Riccardo; Caldart, Federico; DE FRANCESCHI, Lucia; DEL GIGLIO, Micol; Festi, Giuliana; Friso, Simonetta; Frulloni, Luca; Gisondi, Paolo; Krampera, Mauro; Lippi, Giuseppe; Micheletto, Claudio; Piacentini, Giorgio; Pinter, Patrick; Rossini, Maurizio; Schiappoli, Michele; Tecchio, Cristina; Tenero, Laura; Tinazzi, Elisa; Senna, Gianenrico; Carlucci, Matilde, Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach «THE WORLD ALLERGY ORGANIZATION JOURNAL» , vol. 17 , n. 8 , 2024 , pp. 1-15

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo